Use of losartan in FH patients during treatment with DSC-LDL apheresis.
Pintus
S
S
Pintus
P
P
Maxia
P
P
Anedda
S
S
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D001781:Blood Component Removal / Q000009:adverse effects*; D016264:Dextran Sulfate; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000628:therapy*; D007022:Hypotension / Q000517:prevention & control*; D008077:Lipoproteins, LDL; D019808:Losartan / Q000627:therapeutic use*
D008077:Lipoproteins, LDL; D000804:Angiotensin II; D016264:Dextran Sulfate; D019808:Losartan